Literature DB >> 639434

Kinetics of netilmicin and gentamicin.

J A Jahre, K P Fu, H C Neu.   

Abstract

The kinetic parameters of netilmicin were studied in normal human subjects. In the intravenous study a steady-state was obtained in 4 subjects by the constant infusion of 2 mg/kg of netilmicin during the first hour followed by 0.5 mg/kg/hr for each of three successive hours. Creatinine clearance was greater than the simultaneous serum and renal clearance of netilmicin. In the intramuscular study 6 subjects received a single injection of 1 mg/kg of netilmicin followed by the same dose of gentamicin 1 wk later. A mean peak serum levels of 3.9 microgram/ml was found for both antibiotics, but the mean serum half-life of netilmicin was shorter than that of gentamicin. Doubling the intramuscular dose of netilmicin approximately doubled the peak serum level. In both studies 75% to 90% of the netilmicin was recovered in the urine within the first 24 hr. Netilmicin appears to be primarily excreted by glomerular filtration. The apparent volume of distribution was similar to that reported for other related aminoglycosides. Netilmicin and gentamicin have similar kinetic parameters. There were wide individual differences among normal subjects with both drugs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639434     DOI: 10.1002/cpt1978235591

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

Review 1.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 3.  High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.

Authors:  F Sörgel; U Stephan; H G Wiesemann; B Gottschalk; C Stehr; M Rey; H B Böwing; H C Dominick; M Geldmacher von Mallinckrodt
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 4.  Adverse effects of a single dose of gentamicin in adults: a systematic review.

Authors:  Rachel S Hayward; Jan Harding; Rob Molloy; Lucy Land; Kate Longcroft-Neal; David Moore; Jonathan D C Ross
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

5.  Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration.

Authors:  C Lin; C Korduba; M Affrime; E Radwanski; A Nomeir; V Batra; D Cutler; M N Cayen
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

6.  Pharmacokinetics and dosage requirements of netilmicin in cystic fibrosis patients.

Authors:  J A Bosso; P L Townsend; J J Herbst; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

7.  Predicted tissue accumulation of netilmicin in patients.

Authors:  D J Edwards; A Mangione; T J Cumbo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

8.  Correlation of netilmicin disk diffusion susceptibility and agar dilution susceptibility.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

Review 9.  Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin.

Authors:  F Keller; K Erdmann; M Giehl; P Buettner
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

10.  Pharmacokinetic study of sisomicin in humans.

Authors:  M Chung; J J Schrogie; S Symchowicz
Journal:  J Pharmacokinet Biopharm       Date:  1981-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.